Certara Services Archives

Press Coverage

What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?

Explore the top challenges in cell & gene therapy commercialization, featuring expert insights from Fran…

CertaraSeptember 12, 2025

Guide

The Top 10 Things You Need to Know About ADNCA Datasets

Learn how ADNCA datasets can modernize non-compartmental analysis: enhanced compliance, automations, and faster PK data…

CertaraSeptember 11, 2025

On-Demand Webinar

TrialAssure & Certara Joint Webinar: Authoring Clinical Documents with Downstream Regulatory Requirements in Mind

Watch our on-demand webinar from Certara and TrialAssure to learn how to author clinical documents…

CertaraSeptember 10, 2025

Press Coverage

Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research

The article, "Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research," explores a…

Danielle PillsburySeptember 10, 2025

Press Coverage

AI-driven drug discovery picks up as FDA pushes to reduce animal testing

AI is revolutionizing drug discovery and safety testing as drug developers adopt these technologies in…

CertaraSeptember 9, 2025

Conference

Redefining Every Stage of Investment (RESI) Seed to Exit

–

CertaraSeptember 5, 2025

Case Study

Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise

Learn how Certara's project management team helped a large biotech streamline the development and updates…

CertaraSeptember 5, 2025

Blog

Clinical Trials Regulation (EU) No. 536/2014 – The Impact on Annual Safety Reporting

Stay compliant with EU rules for the pharmaceutical industry. Learn about annual safety reports and…

CertaraSeptember 5, 2025

Live Events

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

– London, UK

CertaraSeptember 4, 2025

On-Demand Webinar

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

Watch leading experts from Pfizer, Merck, Amicus, and Certara discuss how Integrated Evidence can bridge…

CertaraSeptember 3, 2025

Certara Services

What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?

The Top 10 Things You Need to Know About ADNCA Datasets

TrialAssure & Certara Joint Webinar: Authoring Clinical Documents with Downstream Regulatory Requirements in Mind

Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research

AI-driven drug discovery picks up as FDA pushes to reduce animal testing

Redefining Every Stage of Investment (RESI) Seed to Exit

Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise

Clinical Trials Regulation (EU) No. 536/2014 – The Impact on Annual Safety Reporting

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

Newsletter sign up

Quick links

Solutions

Contact